ANGO vs PAYX · rev $292.5M vs P/E 22, rev $5.57B
AngioDynamics Inc (ANGO) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
ANGO currently screens at market cap $378.5M. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the ANGO and PAYX stock pages for the full models.
Not investment advice.